August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...

Reports Q4 revenue $2.6M, consensus $3.35M.”With commercial preparations underway, we believe we are well positioned to launch TNX-102 SL for ...

The following is a summary of “Cost-effectiveness and cost-utility of exposure-based vs. traditional cognitive behavior therapy for fibromyalgia: results from a randomized controlled trial,” published ...

The following is a summary of “Treatments for enhancing sleep quality in fibromyalgia: a systematic review and meta-analysis, ...

Various showbiz personalities expressed their support for former host-actress Kris Aquino who praised her youngest ...

The blues and the jitters are very common among people battling chronic pain, a new evidence review says.About 40% of ...

A recently completed study found that certain terpenes in Cannabis sativa are effective at relieving post-surgical and fibromyalgia pain in preclinical models.

Developing myalgic encephalomyelitis/chronic fatigue syndrome is significantly more likely after a case of COVID-19, an ...

Certain terpenes found in moderate to high levels in Cannabis sativa successfully relieved fibromyalgia and post-surgical pain in mouse models. | Cannabis Sciences ...

Of all the treatments for fibromyalgia (FMS) and chronic fatigue syndrome (ME/CFS), antidepressants may be the hardest for people to understand. It's common for people to be confused about why these ...

Objectives Fibromyalgia is commonly considered a stress-related chronic pain disorder, and daily stressors are known triggers. However, the relation between stress and pain development remains poorly ...